Fabrinet (NYSE:FN – Get Free Report) has earned a consensus rating of “Moderate Buy” from the ten brokerages that are currently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $661.75.
Several research firms recently weighed in on FN. Wall Street Zen upgraded shares of Fabrinet from a “hold” rating to a “buy” rating in a report on Sunday, July 12th. Zacks Research lowered Fabrinet from a “strong-buy” rating to a “hold” rating in a research report on Monday, June 15th. Needham & Company LLC reaffirmed a “buy” rating and issued a $800.00 price objective on shares of Fabrinet in a research note on Tuesday, May 5th. Rosenblatt Securities boosted their price objective on Fabrinet from $715.00 to $750.00 and gave the company a “buy” rating in a report on Tuesday, May 5th. Finally, Barclays increased their target price on Fabrinet from $548.00 to $702.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 5th.
Read Our Latest Research Report on Fabrinet
Insider Activity
Institutional Investors Weigh In On Fabrinet
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Divisadero Street Capital Management LP boosted its position in shares of Fabrinet by 57.4% in the 3rd quarter. Divisadero Street Capital Management LP now owns 56,344 shares of the technology company’s stock valued at $20,544,000 after purchasing an additional 20,556 shares during the period. Swedbank AB purchased a new position in shares of Fabrinet during the fourth quarter worth approximately $5,372,000. M&T Bank Corp grew its position in shares of Fabrinet by 196.5% during the fourth quarter. M&T Bank Corp now owns 2,345 shares of the technology company’s stock worth $1,068,000 after acquiring an additional 1,554 shares during the last quarter. JSF Financial LLC acquired a new position in shares of Fabrinet in the 4th quarter valued at $957,000. Finally, HighVista Strategies LLC acquired a new position in shares of Fabrinet in the 3rd quarter valued at $1,860,000. 97.38% of the stock is owned by hedge funds and other institutional investors.
Fabrinet Price Performance
NYSE FN opened at $459.17 on Friday. The stock’s 50 day simple moving average is $600.90 and its 200-day simple moving average is $563.81. The company has a market cap of $16.45 billion, a PE ratio of 39.45 and a beta of 1.20. Fabrinet has a 1-year low of $272.49 and a 1-year high of $748.89.
Fabrinet (NYSE:FN – Get Free Report) last announced its quarterly earnings results on Monday, May 4th. The technology company reported $3.72 earnings per share for the quarter, beating analysts’ consensus estimates of $3.58 by $0.14. The business had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.19 billion. Fabrinet had a net margin of 9.94% and a return on equity of 19.83%. The business’s revenue for the quarter was up 39.3% on a year-over-year basis. During the same period last year, the business earned $2.52 earnings per share. Fabrinet has set its Q4 2026 guidance at 3.720-3.870 EPS. On average, equities research analysts anticipate that Fabrinet will post 12.96 EPS for the current fiscal year.
Fabrinet Company Profile
Fabrinet is a global provider of advanced optical packaging and precision optical, electro‐mechanical and electronic manufacturing services (CEM). The company specializes in complex manufacturing processes for original equipment manufacturers (OEMs) in communications, data center, industrial, instrumentation and medical markets. Key capabilities include high‐precision fiber alignment, micro‐assembly, testing and diagnostics, and integration of electro‐optic subassemblies.
Incorporated in 2000, Fabrinet operates under a corporate structure headquartered in Singapore with additional regional offices and design centers in the Americas, Europe and Asia.
Featured Articles
- Five stocks we like better than Fabrinet
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Fabrinet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fabrinet and related companies with MarketBeat.com's FREE daily email newsletter.
